Your browser doesn't support javascript.
loading
Metformin, the Rise of a New Medical Therapy for Endometriosis? A Systematic Review of the Literature.
Stochino-Loi, Emanuela; Major, Attila L; Gillon, Tessa E R; Ayoubi, Jean-Marc; Feki, Anis; Bouquet de Joliniere, Jean.
Afiliación
  • Stochino-Loi E; Department of Obstetrics and Gynecology, Cantonal Hospital, University of Fribourg, Fribourg, Switzerland.
  • Major AL; Department of Obstetrics and Gynecology, Cantonal Hospital, University of Fribourg, Fribourg, Switzerland.
  • Gillon TER; Femina Gynecology Center, Geneva, Switzerland.
  • Ayoubi JM; Department of Obstetrics and Gynecology, Cantonal Hospital, University of Fribourg, Fribourg, Switzerland.
  • Feki A; Department of Obstetrics and Gynecology, Foch Hospital, University of West Paris, Suresnes, France.
  • Bouquet de Joliniere J; Department of Obstetrics and Gynecology, Cantonal Hospital, University of Fribourg, Fribourg, Switzerland.
Front Med (Lausanne) ; 8: 581311, 2021.
Article en En | MEDLINE | ID: mdl-34046415
Medical treatments for endometriosis aim to control pain symptoms and stop progression of endometriotic lesions. However, their adverse effects and their contraceptive effect in women who desire pregnancy, limit their long terms use. Although there is only one study investigating the effects of metformin on women with endometriosis, metformin seems to have a unique therapeutic potential. It may be a helpful anti-inflammatory and antiproliferative agent in the treatment of endometriosis. As such metformin may be more beneficial thanks to the lack of serious side effects.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Front Med (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Front Med (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: Suiza